BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1646165)

  • 1. Effect of an angiotensin II and a kinin receptor antagonist on the renal hemodynamic response to captopril.
    Fenoy FJ; Scicli G; Carretero O; Roman RJ
    Hypertension; 1991 Jun; 17(6 Pt 2):1038-44. PubMed ID: 1646165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of kinins and angiotensin II in the renal hemodynamic response to captopril.
    Mattson DL; Roman RJ
    Am J Physiol; 1991 May; 260(5 Pt 2):F670-9. PubMed ID: 2035654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of kinins and angiotensin II on the regulation of papillary blood flow.
    Roman RJ; Kaldunski ML; Scicli AG; Carretero OA
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F690-8. PubMed ID: 2845811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinin contribution to renal vasodilator effect of captopril in rabbit.
    Hajj-ali AF; Zimmerman BG
    Hypertension; 1991 Apr; 17(4):504-9. PubMed ID: 1849501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of kinin receptor antagonists on renal hemodynamic and natriuretic responses to volume expansion.
    Fenoy FJ; Roman RJ
    Am J Physiol; 1992 Nov; 263(5 Pt 2):R1136-40. PubMed ID: 1332518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
    Clappison BH; Anderson WP; Johnston CI
    Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
    Heller J; Kramer HJ; Horácek V
    Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinin actions on renal papillary blood flow and sodium excretion.
    Mattson DL; Cowley AW
    Hypertension; 1993 Jun; 21(6 Pt 2):961-5. PubMed ID: 8505107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between inhibition of renal angiotensin II production and hemodynamic effect of captopril in anesthetized rabbit.
    Li T; Zimmerman BG
    J Hypertens; 1992 Aug; 10(8):795-805. PubMed ID: 1325512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II and renal functional reserve in rats with Goldblatt hypertension.
    De Nicola L; Keiser JA; Blantz RC; Gabbai FB
    Hypertension; 1992 Jun; 19(6 Pt 2):790-4. PubMed ID: 1592482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution by bradykinin to the natriuretic response to the angiotensin converting enzyme inhibitor ramiprilat in spontaneously hypertensive rats.
    Sakamoto T; Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):84-9. PubMed ID: 7935859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of renal hemodynamic effect of ramiprilat to captopril; possible role of kinins.
    Chen K; Zimmerman BG
    J Pharmacol Exp Ther; 1994 Aug; 270(2):491-7. PubMed ID: 8071842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal excretory actions of losartan in spontaneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide.
    Munoz-Garcia R; Maeso R; Rodrigo E; Navarro J; Ruilope LM; Casal MC; Cachofeiro V; Lahera V
    J Hypertens; 1995 Dec; 13(12 Pt 2):1779-84. PubMed ID: 8903651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
    Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):194-200. PubMed ID: 7477443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.
    Chamienia AL; Johns EJ
    Br J Pharmacol; 1991 Aug; 103(4):1893-8. PubMed ID: 1833019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
    Gardiner SM; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1996 Dec; 119(8):1619-27. PubMed ID: 8982510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist.
    Xie MH; Liu FY; Wong PC; Timmermans PB; Cogan MG
    Kidney Int; 1990 Sep; 38(3):473-9. PubMed ID: 2232490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.